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The United States has a significant diabetes problem. This chronic disease affects the 
body physically and mentally. One of the emotional effects of diabetes is depression. 
Depression is often present in individuals with diabetes, chiefly in those with type 2 
diabetes mellitus (T2DM). While depression is common in T2DM and can interfere with 
treatment adherence, clinician screening for depression in T2DM patients is low. The 
purpose of this study was to examine clinicians’ attitudes, behaviors, and perceptions 
concerning screening patients with T2DM for depression. Through a qualitative case 
study approach centered on reasoned action theory, 3 physicians and 5 nurse practitioners 
who treated T2DM patients were interviewed. The clinicians were interviewed regarding 
their screening experience for T2DM for depression. Interviews were recorded, 
transcribed and analyzed using thematic analysis. Three themes emerged from the data to 
explain clinicians’ screening of T2DM patients for depression: 1) clinicians’ focus on 
treating the physical disease of diabetes rather than comorbid depression, 2) T2DM 
depression screening is accepted as a standard of care or part of the clinical assessment 
process, and 3) there is favorable perception of peer approval for T2DM depression 
screening. Implications for social change relate to the need for those with T2DM to 
receive effective and efficient screening and treatment for depression. The role of 
diabetes clinicians could provide a consistent point of care for screening and referral for 
filling this need. Development of best practice guidelines and relevant education 
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Chapter 1: Introduction to the Study 
Diabetes is a chronic disease that is a severe global health problem. In 2010, the 
International Diabetes Federation provided statistics showing that 330 million individuals 
have diabetes worldwide. (Centers for Disease Control and Prevention [CDC], 2014). 
The occurrence of diabetes in Western societies is rapidly rising, and global healthcare 
expenditures for diabetes are expected to total $490 billion by 2030 (CDC, 2014). In the 
United States, diabetes effects many people, and Type 2 diabetes in young adults is 
growing at an alarming rate (CDC, 2015). Diabetes affects an individual’s physical and 
mental health, life expectancy, and can cause physical complications (CDC, 2014) that 
lead to depression. Depression is a comorbid disease with diabetes (Heckbert, Rutter, 
Oliver, Williams, Ciechanowski, Katon, & Von Korff, 2010), meaning that depression 
can present simultaneously in a patient living with diabetes. 
This study focused on depression in adults with Type 2 Diabetic Mellitus (T2DM) 
and indicated how physicians screen patients with T2DM for depression. This chapter 
provides background information concerning T2DM and depression. The next section 
addresses the statement of the research problem, the purpose and nature of the study, and 
the research questions. I also discuss the research methodology, definitions, assumptions, 
scope, delimitations, limitations, and significance of the study, and end with a summary 
of the chapter. 
Background 
In the United States, 30.3 million people, or 9.4% of the population, have 




Diabetes is diagnosed in individuals of all ages each year. According to the CDC (2017), 
diabetes rates as the seventh leading cause of death in the United States. The financial 
cost of diabetes in the United States was assessed to be $176 billion in direct health costs, 
such as medical services, and $69 billion in indirect expenses from missing workdays, 
limited activity, disability, and early mortality (CDC, 2014). 
Diabetes is a metabolic disorder caused by genetic and environmental factors that 
lead to an unusually high blood sugar level know as diabetes mellitus (DM), which 
indicates impaired insulin secretion. Insulin secretion is a process in the human body that 
primarily occurs in response to glucose levels becoming elevated in the blood. Insulin 
resistance increases the hepatic production of glucose, making insulin levels inadequate 
to normalize plasma glucose levels. Causes of diabetes include heredity, poor diet, 
lifestyle, gender, stress, and lack of exercise (CDC, 2014).  
Individuals with parents who have diabetes are most likely to develop the disease, 
and the incidence of diabetes seems to increase with age (CDC, 2015). Dietary deficits in 
fiber, protein, and overall nutrition may contribute to diabetes. A lifestyle that does not 
include regular exercise and includes high stress may contribute to developing diabetes 
(CDC, 2015). Ethnic groups including African Americans, Hispanics/Latinos, Indians, 
Asians, and Native Hawaiians or Pacific Islanders are at a higher risk for developing 
T2DM than Whites (CDC, 2014).  
Depression is one of the complications of T2DM and is two to three times more 
prevalent in persons with T2DM than in the general population (Carpenter, 2010). 




disorder, debility, health deterioration, high healthcare expenditures, and premature 
mortality (O’Connor, Crain, Rush, Hanson, Fischer, & Kluznik, 2009). Signs of 
individuals with T2DM depression involve a decline in sexual desire, alteration in 
appetite, and sleep alteration.  
Feeling sad for more than two weeks is considered the onset of depression (Yim, 
Adelina, Tsang, & Leug, 2009). Antidepressants and counseling have shown to 
effectively reduce major depression and improve glycemic control in a person with 
T2DM (Yim et al., 2009). Individuals with depression may display anger and guilt; both 
are commonly seen in people with chronic diseases like diabetes (Ahlin & Billhult, 
2012). Depression in the T2DM population is also related to poor health-behavior 
compliance, which can negatively affect disease management (Ducat, Philipson, & 
Anderson, 2014). The medical costs for treating individuals with T2DM in the United 
States is $10,016 annually (Bogner & de Vries McClintock, 2016). An individual 
diagnosed with T2DM depression may have medical costs of approximately $15,155 for 
annual medical treatments (Egede, Walker, Bishu, & Dismuke, 2016). Individuals with 
T2DM and unrecognized depression could result in medical cost of approximately 
$16,134 for annual treatments (Bogner & de Vries McClintock, 2016). Additionally, 
individuals with T2DM and asymptomatic depression incurred a medical cost of 
approximately $20,105 for annual treatments (Egede, Walker, Bishu, & Dismuke, 2016).  
A comprehensive approach to treating individuals with T2DM might prove 
beneficial to treating the onset of disease complications; however, the American Diabetes 




not include screening patients for depression (National Diabetes Statistics, 2011). It is 
recommended that individuals with chronic diseases change their daily routines to 
manage their chronic illness. T2DM is a chronic disease that requires individuals to 
incorporate new methods to accommodate the complications of their illness, which can 
sometimes lead to depression (Mezuk, 2011). Recommendations to assist individuals 
diagnosed with T2DM are maintain a healthy lifestyle include exercise regimens, 
preparation of specialized meals, and following time schedules for medications; these 
requirements can cause high-stress levels as individuals with diabetes work to regulate 
their bodies’ glucose (Heckbert et al., 2010). 
Individuals with diabetes are more likely to experience depression and diminished 
health than those without diabetes (Egede & Ellis, 2010). Depression can emerge in 
individuals with T2DM due to the prolonged stress that can result from living with a 
chronic illness (Egede & Ellis, 2010). Adopting a comprehensive approach to treating 
individuals with T2DM may prove beneficial to treating the onset of disease 
complications that may result due to bouts of depression.  
Problem Statement 
Despite an abundance of research that examined the relationship between diabetes 
and depression in the general population (Yu, Y-Hua, & Hong, 2010), there is no 
research that examines managing depression in patients with T2DM. Additionally, there 
are no studies that have examined physicians’ depression-screening behavior during 




need to examine physicians’ attitudes and behaviors concerning screening individuals 
with T2DM for depression. 
Because physicians lack the practice of depression screening, individuals with 
T2DM are often undiagnosed during the early stages of depression onset (Culman, Guja, 
Mihai, & Serafinceanu, 2013), resulting in disease management being compromised for 
these patients (Culman, Guja, Mihai, & Serafinceanu, 2013). Researchers have 
demonstrated a connection between diabetes and depression; however, screening for 
depression in individuals with T2DM is unlikely to occur (Heckbert, Rutter, Oliver, 
Williams, Ciechanowski, Lin, Katon, & Von Korff, 2010). Therefore, it is essential to 
establish criteria for adequate treatment of individuals with T2DM who suffer from 
depression, which could lead to improving their quality of life (Pouwer, 2017). Based on 
Connor, Crain, Rush, Hanson, Fisher, and Kluznik (2009), research revealed that 
depression and diabetes have a bidirectional relationship, which shows the importance of 
managing T2DM depression. Many physicians fail to treat the psychosocial and 
emotional difficulties of T2DM (Beverly, Hultgren, Brooks, Ritholz, Abrahamson, & 
Weinger, 2011). There is an important need for physicians to recognize depression in 
patients with T2DM (Culman, Guja, Mihai, & Serafinceanu, 2013). Screening for 
depression and providing integrating psychosocial and behavioral healthcare to T2DM 
patients could ensure that physicians manage both diseases (Egede & Ellis, 2010). 
According to Beverly et al. (2011), physicians reported limited patient-treatment 
choices, time limits of patient appointments, and a lack of mental disorder expertise, 




of efficient psychological testing and short-term psychosocial interventions that doctors 
used were essential to individuals’ health; however, they should not replace mental well-
being referrals (Beverly et al., 2011). Medical preparation and training should address 
psychosomatic complications that frequently occur in patients with prolonged illnesses. 
Doctors and patients may benefit from a multidisciplinary team method in which team 
members supplement care by providing assessment and treatment for patients’ 
psychosocial and emotional complications (Beverly et al., 2011). 
From economic, public health, and humanitarian standpoints, identifying and 
treating mental health comorbidities among diabetes patients should be a priority (Ducat 
et al., 2014). Individuals with T2DM are particularly vulnerable to mental health 
comorbidities, as they experience challenges in their ability to maintain an average 
glucose level and risk a medical loss to follow-up on poor health outcomes. Creating an 
opportunity to integrate mental health screening and treatment into multidisciplinary team 
care for T2DM could improve patient and public health outcomes and help decrease 
healthcare expenditures (Ducat et al., 2014). According to ADA (2014) standards of care, 
people with T2DM should receive medical attention from a panel of healthcare 
professionals that includes physicians (medical practitioners, general practitioners, and 
internal medicine), nurse practitioners, physician’s assistants, nurses, dietitians, 
endocrinologist, pharmacists, and psychiatrists with expertise in diabetes. 
A limited number of diabetic clinics offer mental health screening or incorporate 
mental and behavioral health services for T2DM in diabetes clinical care (Garrusi, 




affordable to use standardized psychiatric diagnostic interviews to diagnose mental health 
comorbidities in individuals with T2DM. T2DM depression interferes with individuals’ 
disease management, and there is a need to identify screening behaviors among 
physicians. Understanding the clinicians’ viewpoints as to why physicians may or may 
not screen T2DM patients for depression could result in the development of a T2DM 
screening plan to treat both T2DM and depression. 
Purpose of the Study 
The purpose of the study was to examine clinician behaviors and attitudes towards 
screening for depression in patients with T2DM. In this qualitative study, I explored how 
doctors describe their perspectives and behaviors relating to depression screening in their 
patients with T2DM.  
Research Questions 
The investigation questions that guided this study were: 
1. How do physicians and nurse practitioners describe their attitudes toward 
screening T2DM patients for depression? 
2. How do physicians and nurse practitioners describe their T2DM depression-
screening behaviors? 
3. How do physicians and nurse practitioners describe their perceptions of 
whether their peers support screening T2DM patients for depression? 
These open-ended questions align with tenets guiding on qualitative inquiry (Creswell, 




clinician’s perspective and behavior when screening individuals with T2DM for 
depression. 
Conceptual Framework 
Scholars have used the theory of reasoned action (TRA) to explain a range of 
clinical practices among physicians and other healthcare professionals (Ajzen & 
Fishbein, 1980). TRA is a model used to explain behavior that emphasizes behavioral 
intention, attitudes, and subjective norms (Ajzen & Fishbein, 1980). Behavioral intention 
measures the probability that an individual would participate in a particular behavior or 
harbor the intent to implement or not implement a given behavior (Ajzen & Fishbein, 
1980; Thrasher, Andrew, & Mahony, 2011). 
The behavioral intention has two factors, one individual in nature and the other 
reflecting social impact. The personal influence is the individual’s positive or negative 
assessment of executing the behavior or attitude regarding the behavior (Ajzen & 
Fishbein, 1980, p. 6). Attitude or viewpoint refers to the degree to which an individual 
has an encouraging or undesirable assessment or review of the behavior in question. 
Personal norms relate to an individual’s beliefs about whether peers and individuals of 
importance believe they should engage in the behavior (Thrasher et al., 2011). An 
individual may evaluate viewpoint and personal norms directly or indirectly. The direct 
assessment of attitude is the overall evaluation of conduct. The indirect assessment rests 
on a person’s beliefs that engaging in the behavior aligns with specific consequences 




A behavioral view of screening people with T2DM for depression may result in 
the likelihood that screening would enhance patient health choices and may be weighed 
by the person’s evaluation that the behavioral outcome of improving the health of 
individuals with T2DM is good (Ajzen & Fishbein, 1980). The direct assessment of 
attitude is the overall evaluation of the behavior (screening a T2DM patient for 
depression is right or wrong). An indirect assessment of a person’s attitude is related to 
the individual’s belief that engaging in the behavior is associated with specific 
consequences (behavioral beliefs), weighed by an evaluation of that result (Ajzen & 
Fishbein, 1980).  
The direct measure is the individual’s overall evaluation of whether social 
referents approve or disapprove of behavior (Ajzen & Fishbein, 1980). The secondary 
measure is the person’s belief that each specific referent endorses or rejects behavior, 
weighed by the individual’s motivation to comply with referents’ perspectives. 
Clinicians’ opinions of colleagues’ endorsement or lack of endorsement of screening 
those with T2DM for depression are likely to influence their motivation to screen. I used 
TRA, which was the foundational theoretical model for this study. It is useful as an 
analysis of clinicians’ intention to screen T2DM patients for depression. I explored how 
doctors and nurse practitioners describe their perspectives and behaviors relating to 
depression screening in their patients with T2DM.  
Nature of the Study 
This qualitative case study focused on how clinicians screen patients with T2DM 




used in this research (Creswell, 2007). Focus groups were not considered in this study 
because I wanted the participants to discuss their experiences in a private setting and 
avoid the tendency of not being completely honest because of what others in a group 
setting might think.  
Quantitative and mixed methods were not appropriate because this study was not 
about numbers and trend analysis (Creswell, 2014). I recorded the interviews, and the 
recordings were transcribed, using NVivo to develop categories (Creswell, 2014). NVivo 
software is an aid in manipulating the data, developing codes, and categorizing the data 
(Creswell, 2014). 
This qualitative research used purposeful sampling; this means that the inquirer 
selects individuals and sites for the study to purposefully understand the research problem 
in the case study (Creswell, 2007). According to Creswell (2007), the recommendation 
for conducting a qualitative case study should contain no more than five to ten 
participants in a single study. This sample provided sufficient opportunity to identify 
themes of the cases and conduct cross-case theme analysis (Creswell, 2007). 
Definitions 
Definitions presented below include biological and medical terms and diagnostic 
tools used in this dissertation. 
Blood cholesterol: This is a type of fat produced by the liver, found in the blood 





Blood glucose: This is sugar in the blood that provides the body with the primary 
source of energy (CDC, 2014). 
Comorbidity: This consists of two or more diseases or conditions in patients. 
Comorbidity sometimes refers to complications in the disease (CDC, 2014). 
Depression: This is a mood disorder that causes a continuous feeling of anxiety, 
sadness, misery, withdrawal from society, and loss of interest (CDC, 2014). 
Depression screening: This is a mental health tool used to determine if an 
individual is depressed. Depression screening is used to determine if individuals are 
feeling an overwhelming sadness (CDC, 2014). 
Diabetes: This is a metabolic disorder that involves multiple organs, including the 
brain and central nervous systems. High blood glucose or hyperglycemia results from the 
body’s inability to use blood glucose for energy (CDC, 2014). 
Diabetes Mellitus (DM): Classified as impaired insulin secretion and peripheral 
insulin resistance, this increases hepatic production of glucose, making insulin levels 
insufficient to regulate plasma-glucose levels (CDC, 2014). 
Diagnosing diabetes: This includes a diabetes atlas application. A person is 
considered to have been diagnosed with diabetes if a doctor or other medical health 
professional told an individual they had diabetes. Women who had diabetes during 
pregnancy are not considered to have diabetes (CDC, 2014). 
Hypoglycemia: This is low blood glucose. It is a disorder that occurs when one’s 




tremors, sweat, faintness or dizziness, lethargy, and confusion. If left untreated, 
hypoglycemia may lead to unconsciousness (CDC, 2014). 
Neuropathy: This is an ailment of the nervous system that causes muscle 
weakness, ache, and numbness. The most common form of neuropathy in people with 
diabetes is peripheral neuropathy, which affects the legs and feet (CDC, 2014). 
Obesity: This is a disorder in which a person has a higher than average amount of 
fat in the body or has a body-mass index of 30 or more (CDC, 2014). 
Type 2 Diabetes Mellitus (T2DM): This is an ailment categorized by high blood-
glucose levels caused by the lack of insulin or the body’s incapacity to use insulin 
efficiently. Individuals with T2DM often develop the illness during middle-age. T2DM 
can appear in children and teens, as well as adults (CDC, 2014). 
Theory of Reason Action Model Constructs 
Behavior: This is the transmission of intention or perceived behavioral control 
into action (Ajzen & Fishbein, 1980).  
Behavioral Intention: This is an indication of how hard people are willing to try 
and how much effort they are planning to use to perform a behavior (Ajzen & Fishbein, 
1980).  
Attitude: This is the first determinant of behavioral intention. It is the degree to 
which the person has a favorable or unfavorable evaluation of the behavior in question 




Subjective Norm: This is considered the second predictor of behavioral intention, 
and it is influenced by social pressure to perform or not perform a specific behavior 
(Ajzen & Fishbein, 1980).  
Perceived Behavioral Control: This is the third precursor of behavioral intention 
(Ajzen & Fishbein, 1980). This construct is defined as the person’s belief concerning 
how easy or difficult performing the behavior will be (Ajzen & Fishbein, 1980).  
Assumptions 
The following assumptions relate to participant responses and the data used in the 
analysis portion of the research. The first assumption was that participants have an 
opinion about T2DM screening for depression. The second assumption was that 
clinicians were thoughtful and honest in their answers to the research questions. The third 
assumed that clinicians had experience treating patients with T2DM depression. The 
fourth assumption was that participants who agreed to participate met the study’s criteria.  
Scope and Delimitations 
Physicians and nurse practitioners were invited to participate in this case study 
research. Participants were recruited from Saint Louis, Missouri, and the following cities 
in Mississippi: Charleston, Horn Lake, Calhoun City, Pora, Hernado, and Pope. Specialty 
areas of participants included medical practitioner, general practitioner, endocrinologist, 
family medicine, and internal medicine. The focus was on physicians’ and nurse 
practitioners’ treatment process for patients with T2DM accompanied by depression. 




treatment. There was no way to identify which participants made which statement. Study 
results were not generalized due to the limited number of five to seven participants. 
Limitation 
This research study is limited to a focus on clinicians’ screening of patients with 
T2DM for depression. Another limitation was that if physicians and nurse practitioners 
understand T2DM depression exists and if they included screening of patients with 
T2DM for depression. A potential weakness of the study was not knowing if physicians 
integrated T2DM depression screening into their daily clinical practice. The final 
limitation of the study was that the data collected from a small group may not have 
yielded an accurate picture of the present population, and generalization of the results 
may have been ambiguous because of the limited number of interviews. 
Significance  
This study produced significant knowledge and additional insight into T2DM 
depression screenings. The study and research questions aimed to examine clinicians’ 
attitudes and behaviors concerning screening patients with T2DM for depression. 
According to Ajzen and Fishbein (1980), the attitude was populated to be the primary 
factor of behavioral intention. The individual attitude towards behavior is the degree to 
which one has a positive or negative belief about performing a correct behavior. An 
individual is intended to implement a particular behavior when he or she assesses it to be 
positive or an individual does not intend to perform a particular behavior when he or she 




According to Ajzen and Fishbein (1980), subjective norms or normative beliefs 
are considered the second predictor of behavioral intention. Subjective norms or 
normative beliefs are the peer pressures interpreted by the individual to exhibit or not 
exhibit a particular behavior (Ajzen & Fishbein, 1980). An individual is intended to 
perform a specific behavior when he or she perceives what others think they should 
(Ajzen & Fishbein, 1980). An individual not intending to implement a specific behavior 
once they perceive that it is not necessarily based on if others think (Ajzen & Fishbein, 
1980). The behavioral intention was weighed by the individual’s desire to comply with 
perceived expectations. Perceived behavioral control is the third precursor of behavioral 
intention (Ajzen & Fishbein, 1980). 
Understanding behavioral control refers to the degree to which some individuals 
feel that accomplishing or not accomplishing the behavior in question is under their 
control (Ajzen & Fishbein, 1980). People are not likely to form an opinion to perform a 
behavior if they do not have resources or opportunities to do so, even if they hold positive 
attitudes toward the behavior and believe that others would approve of it (Ajzen & 
Fishbein, 1980). Understanding behavioral control can influence behavior directly or 
indirectly through behavioral intentions. A route from perceived behavioral control to 
behavior is likely to emerge when there is some agreement between the control’s 
perceptions and the person’s actual control over the behavior (Ajzen & Fishbein, 1980).  
This study has information for medical professionals, improving their 
understanding of the level of T2DM depression, thereby allowing them to treat 




medical community with additional knowledge on how to screen individuals with T2DM 
depression. Educating health professionals on types of depression is one approach to 
improving T2DM depression care. Continuing education programs would enhance 
providers’ intentions, confidence, and skills to address depression in patients with T2DM. 
Healthcare professional training on depression scales for T2DM should be current, 
credible, focused, engaging, comfortable to use, and convenient for the doctors (Osborn 
et al., 2010). It is essential to providing the medical community with an understanding of 
the psychological, emotional, and social impact of T2DM depression (Speight, Browne, 
Holmes-Truscott, Hendrieckx, & Pouwer, 2012). Physicians need to support people 
living with T2DM depression, promote positive health habits, and enhance the health and 
well-being of the T2DM population (Nelson & Prilleltensky, 2005). This study could 
bring increased awareness regarding the doctors’ current behaviors and practices treating 
the T2DM population. 
Summary 
A need exists to increase T2DM depression awareness by screening diabetic 
patients. This diabetic screening goal was attained by incorporating screening tools for 
depression as part of regular diabetes procedures (Schram, Baan, & Pouwer, 2009). 
Acknowledging depression in individuals with diabetes is suboptimal. A universal 
approach to launching comprehensive interventions to improve early detection of 
depression and early initiation of treatment for depression is required to reduce the 
world’s depression burden among individuals with diabetes (Egede & Ellis, 2010). 




treatment. Understanding this complex co-occurring condition is essential, and healthcare 





Chapter 2: Literature Review 
Introduction 
The research purpose of this study is to explore physicians’ and nurse practitioners’ 
perceptions and behaviors regarding screening patients with T2DM for depression. The emphasis 
of this research study was to examine clinicians’ behavior and impact of peer influence on 
screening T2DM patients for depression. There are no research studies that examine how 
primary care physicians, endocrinologists, nurse practitioners, and internal medicine physicians 
screen individuals with T2DM for depression. This chapter reviews the literature on diabetes, 
T2DM, deficiency of depression screening, psycho-diagnostic, depression, cost of T2DM 
treatment, and the TRA.  
Depression in diabetic patients is often unrecognized and untreated because of the 
similarity to somatic symptoms (Culman et al., 2013). Another reason for the deficiency of 
depression screening for diabetes patients includes clinicians improperly trained to perform 
psycho-diagnostic interviews (Culman et al., 2013). Healthy individuals who do not have a 
chronic disease such as diabetes may not experience an increase in their annual healthcare cost. 
However, for individuals who develop chronic diseases such as diabetes, healthcare costs may 
increase, resulting in feelings of depression. My qualitative research focus was on T2DM, 
depression, and clinicians’ behavior toward T2DM depression screening. 
Literature-Search Strategy 
The literature search was conducted using an online questionnaire to identify peer-
reviewed articles from January 1990 through June 2017 using Thoreau and Walden University’s 




following are resources from the databases: Thoreau, Biomed Central, CINAHL, EBSCOhost, 
Elsevier, JAMA, and Google Scholar. Additional databanks perused were Medline, Psych 
Articles, PsycINFO, Social Science, Sage, ProQuest, Web of Science, PubMed, and Science 
Direct peer-reviewed journal articles. The search consisted of retrieving full English text from 
published journal articles. Key terms were diabetes, diabetic, non-insulin-dependent diabetes 
mellitus, depression, and comorbidity of T2DM, combined with depression or depressive, mood 
disorder, depressed mood, risk factors, complications, glycemic control, mortality, and 
healthcare costs.  
Conceptual Framework 
Ajzen and Fishbein (1980) define TRA as a general theory explaining individual 
behaviors and identifying intention determinants. According to TRA, a person’s intention is a 
function of two primary determinants, one person in nature and the other reflecting social 
influence (Ajzen & Fishbein, 1980). The particular factor is the individual’s positive or negative 
evaluation of performing a behavior; this aspect is the behavior’s attitude. The second 
determinant of the intention is the person’s perception of the social pressures to perform or not 
perform the behavior in question (Ajzen & Fishbein, 1980). According to TRA, individuals plan 
to perform a behavior when they evaluate it positively and believe that significant others think 
they should perform it (Ajzen & Fishbein, 1980). TRA serves as the theoretical framework for 
this study. Examining physicians’ behavior using the TRA as a theoretical lens, this study 
explored clinicians’ depression-screening behaviors, attitudes toward screening, and perceptions 




TRA is a model explaining individual behaviors, emphasizing intention, attitudes, and 
perceptions of whether peers support a particular activity (National Institutes of Health [NIH], 
2012). According to TRA, an individual who believes performing a given behavior would lead to  
a positive outcome would hold a favorable attitude toward performing that behavior and would 
be more likely to carry out the behavior. Similarly, if an individual believes others approve of the 
behavior, he or she would be more likely to hold a positive attitude toward it and be more likely 
to perform the behavior. In this study, I used TRA to identify why clinicians may or may not 
hold favorable attitudes toward screening for depression in T2DM patients. I further used TRA 
in this study to understand clinicians’ attitudes toward screening for depression and how those 
attitudes are similar in intentions to monitor individuals with T2DM for depression. 
Qualitative Case Studies 
Creswell (2009) recommended that qualitative researchers choose from among the 
possibilities of narrative, phenomenological, ethnographic, case, and grounded-theory study. 
Currently, these methodologies are widespread across social and health sciences (Creswell, 
2009). Case studies are a plan of inquiry in which the investigator explores in depth a program, 
event, activity, process, individual, or group (Creswell, 2009). A case study is limited to time, 
activity, and the researcher’s ability to gather comprehensive information, exhausting an 
assortment of data collection procedures over a continued period (Creswell, 2009). This process 
encompasses using numerous points of data collection and the refinement and interrelationship 
of categories of information (Creswell, 2009). 
Case studies are standard in the medical field to investigate or search for understanding of 




nursing staff’s confidence in their knowledge of prostate cancer’s psychosocial influence was 
explored using a case study research approach (Williams, Hemphill, & Knowles, 2017). In one 
example of a case study on the practice of social work in health care in the Czech Republic, the 
researcher worked to understand social work practice in healthcare through exploration 
(Kuznikova, 2017). Another example of a case study was a UK education program affecting 
healthcare professionals to recommend exercise for their patients with T2DM, which enabled 
them to understand their processes (Matthews, Jones, Thomas, van den Berg, & Foster, 2017). 
Lastly, an example of a single-case cross sectional study was conducted to understand the 
dissemination of an accident, emergency, attendance, and hospital admissions for the case-
managed population (Phillips, Jones, Runacres, Lintern, & Radford, 2016).  
Qualitative Concerns and Procedures 
Qualitative researchers usually do not test concepts or assumptions. It is essential to 
deliberate critical concepts from related information that contribute to current understanding and 
concepts that assist in data interpretation qualitative case study should be conducted to 
understand T2DM depression screening behaviors. In this project, I studied clinicians’ current 
screening behaviors, attitudes, and perceptions of whether their peers support screening patients 
with T2DM for depression.  
For this study, the interviewees consisted eight clinicians. This sample size achieved 
saturation of themes as suggested by Isaacs, 2014. A snowball sampling technique was used to 
identify potential interviewees for this study. Snowball sampling is where research participants 
recruit other participants for a study. The demographic data collected described the sample and 




This qualitative case study focused on the experience of clinicians treating individuals 
with T2DM. Questions pertained to clinicians’ experience and processes, and attributes toward 
treating patients with T2DM. A qualitative case study design was employed because it permits 
clinicians to describe their process for screening patients with T2DM for depression. 
Literature Review Related to Key Variables and/or Concepts 
Type 2 Diabetic Mellitus and Depression 
T2DM is a long-lasting metabolic disorder (Kolluru, Bir, & Kevil, 2012) that causes an 
individual to develop abnormal blood-glucose levels, carbohydrates, fat metabolism, and protein 
metabolism (Abbas et al., 2015). The human body converts food into glucose (sugar) for the 
body to consume as energy. The pancreas is an organ located between the stomach and spine that 
produces hormones commonly referenced as insulin. Insulin transfers glucose from the blood 
into muscle, fat, and liver cells to power the human body (CDC, 2014). Individuals with DM 
produce insufficient insulin. If individuals do not produce adequate amounts of insulin, sugar 
accumulates in the bloodstream (CDC, 2014). Individuals with DM are at a higher risk of 
developing a range of comorbidity complications due to the disease (CDC, 2014). 
Diabetes generates serious health problems: chronic renal disease, cardiovascular disease, 
diabetic eye disease, lower extremity amputations, and comorbidities such as depression. 
Depression and diabetes are linked; therefore, better management of DM could reduce patients’ 
likelihood of experiencing an episode of depression (Abbas et al., 2015; Alderson, Foy, 
Glidewell, & House, 2014).  
Diabetes is the seventh leading cause of death in the United States (CDC, 2014). 




diabetes. T2DM individuals account for roughly 90 to 95% of all identified cases of diabetes. 
Risk factors for developing T2DM are age, weight, family history, occurrence of gestational 
diabetes, physical activity, and race or ethnicity. Nearly 8.1 million individuals with diabetes do 
not realize they have the disease due to prediabetes and T2DM having limited physical 
symptoms. Therefore, some individuals might not realize the severity of the disease (CDC, 
2014). In the United States, diabetes trends have nearly multiplied within 5 years, from 5.5 
million to 21.3 million adult cases. Each year, healthcare personnel report 1.7 million new adult 
cases of diabetes. If this trend continues, one of every three adults in the U.S. might haveT2DM 
diabetes by 2050 (CDC, 2014). 
Type 2 Diabetic Mellitus and Depression Symptoms 
T2DM depression causes feelings of sadness, anxiety, and withdrawal from society 
(Auslander, Sterzing, Zayas, & White, 2010). Mental illness symptoms include depression, sad 
mood, reduced interest in activities, weight change, psychomotor tension, exhaustion, 
inappropriate remorse, and difficulties focusing (CDC, 2014). One of the diagnostic criteria 
established by the American Psychiatric Association suggested five or more characteristics or 
symptoms must be present for a continuous period of 2 weeks to be classifiable as depression 
(CDC, 2014). An individual with T2DM might suffer from one or more depressed mood 
symptoms, may develop insomnia from worries about uncontrollable glycemic levels, or have a 
negative self-concept (Yim et al., 2009). Depression is a condition that affects cognition, 
behavior, and the nervous system, leading to significant dysfunction in an individual’s daily life 




Treatment for depression consists of psychotherapy, drugs, and individual counseling. 
Depressed patients have a high risk of suicidal ideation, and some depression treatment offers 
patients alternative therapy treatment. For example, aromatherapy is a useful tool to treat 
depression. According to Siddique et al. (2014), research showed that T2DM patients have a 
higher clinical depression rate than insulin-treated patients. The etiology of depression is 
unknown; however, genetic and environmental factors may contribute (Coryell, 2009). 
Depression also affects the immune system by reducing the protection response and intensifying 
the risk of cardiovascular disorders. 
Depression in Type 2 Diabetic Mellitus  
Wiltink, Michal, Wild, Schneider, König, Blettner, Beutel, (2014) identified a clear 
association between diabetes and depression. Individuals with T2DM risk developing depression, 
nervousness, or food-intake disorders (Ducat et al., 2014). Individuals with diabetes may 
experience specific emotional difficulties, such as feelings of shame or apprehension when they 
fail to persist in their diabetes management. This population may fail to receive treatment due to 
inadequate screening for mental health comorbidities such as depression. Clinicians should 
identify and treat mental health comorbidities of individuals with T2DM due to the risk that 
depression poses to adhering to medical-treatment plans (Alonso-Moran, Satylganova, Orueta, & 
Nuno-Solinis, 2014; Ducat et al., 2014). If depression remains untreated, patients with T2DM 
may not correctly manage their illness, leading to physical complications. 
The connection between diabetes and depression is bidirectional (Heckbert et al., 2010). 
Individuals with diabetes have a higher degree of developing depressive illness, and depression 




diabetes intensify one another, contributing to a catastrophic cycle of poor self-care, deteriorating 
diabetes control, and deepening depression (Culman et al., 2013). However, depression is 
considered an insignificant factor, frequently ignored and left untreated by medical professionals 
(Zhang, Ajilore, Zhan, GadElkarim, Korthauer, Yang, & Kumar, 2013). 
Why Individuals with T2DM are Susceptible to Depression 
Depression is a common problem with diabetes; recent meta-analysis acknowledged 
depression is two to three times more dominant in individuals with diabetes than in the general 
population (Carpenter, 2010). Depression, combined with DM, is a significant burden on 
patients’ health (Abbas et al., 2015). Sweileh, Abu-Hadeed, Al-Jabi, and Zyoud (2014) 
recommended instituting a psychological assessment in the diabetic healthcare plan, reducing the 
number of unrecognized diabetic patients with depression. The researchers also recommended 
that routine clinical evaluations include psychosocial assessment conducted by patients’ primary 
healthcare clinics to improve patients’ quality of life. 
For several years, researchers identified the relationship between depression and diabetes. 
Investigators argued that diabetes precede depression and leads to depression through a direct 
effect of hyperglycemia. Individuals with diabetes develop depression as a consequence of 
psychological tension that elevates the acknowledgment of the diagnosis. Diabetes treatment 
requires lifestyle modifications and medication that cause depression symptoms (Holt et al., 
2009). Better management of DM would reduce the likelihood of a patient with diabetes 
experiencing an episode of depression (Abbas, Nasir, Zehra, Noor, Jabbar, & Siddqui, 2015, p. 




Psychosocial interventions for the T2DM population include treating diabetic distress and 
depression simultaneously (Carper et al., 2014). 
Diabetes and depression mutually worsen the other with each ailment acting as a risk 
factor in the development of the other (Zhang et al., 2015). Individuals with T2DM depression 
symptoms may experience increased disability, a decline in health, increased medical expenses, 
and premature death (O’Connor et al., 2009). A diabetic’s self-care management program 
requires balancing a complex set of behavioral tasks. The individual must adhere to prescribed 
medications 24 hours a day and maintain their self-care plan overall (Ducat et al., 2014). 
Diabetes suffering occurs because almost all diabetic care involves self-management. Self-
management tasks for patients with T2DM consist of carefully testing blood glucose levels to 
regulate medication doses day and night (Aflakseir, & Malekpour, 2015). Patients with T2DM 
balance their insulin level by selecting specific foods to eat and monitoring their blood glucose 
levels to prevent hypoglycemia (Ducat et al., 2014). Individuals with T2DM experience specific 
emotional complications, such as feeling guilty or depressed when they fail to maintain their 
diabetes regimen (Lee, Chapa, Kao, Jones, Kapustin, Smith, & Friedmann, 2009). 
A person with diabetes has emotional responses to the experience of having T2DM with a 
wide range of stressors, such as feeling overwhelmed with the diabetes regimen (Ducat et al., 
2014). Patients with T2DM are concerned about the future and the possibility of severe 
complications and feel guilty when management is going poorly. The disease mandates self-
management, causing emotional distress to individuals with T2DM. T2DM psychiatric diagnosis 
of depression aligns with poor compliance with treatment, glycemic control, higher percentages 




Lifestyle alterations provide persisting inner struggles for the population with T2DM 
(Ahlin & Billhult, 2012). This population struggles to prepare healthy food for the family and 
lifestyle changes are overwhelming (Pera, 2011). Furthermore, women with T2DM often place 
family needs first, causing them to manage their disease inadequately (Pera, 2011). Individuals 
with DM feel a loss of independence. They also experience frustration during meticulous 
planning around diabetes that can interfere with freedom of choice, particularly in those who are 
new to the condition. Emotional distress is a core development for individuals with T2DM, and 
healthcare personnel must continuously measure underlying diabetes-related distress (Fisher, 
Gonzalez, & Polonsky, 2014). Continuous diabetes distress measurement can lead to suitable and 
targeted patient interventions (Fisher et al., 2014). Patients with diabetes should have regular 
screening for depression to reduce the number of depressed or misdiagnosed patients, offering 
them a healthier quality of life (Zhang et al., 2015). 
Treatment for Type 2 Diabetic Mellitus 
The American Diabetes Association has developed national guidelines for treating 
patients with T2DM. However, the guidelines do not include depression treatment, nor do they 
require annual depression screenings for patients with T2DM. Depression can be a severe 
problem for patients with diabetes (Gonzalez, Fisher, & Polonsky, 2011). Additionally, 
healthcare providers do not educate patients with T2DM about depression or the consequences of 
depression for disease management (National Diabetes Statistics, 2011). Consequently, a vast 
number of individuals with T2DM are unaware of the symptoms of depression and do not know 
to request medical treatment (Agbir, Audu, Adebowale, & Goar, 2010; Yu et al., 2010). Patients 




depression screening in the medical community (De Groot, Kushnick, Doyle, Merrill, McGlynn, 
Shubrook & Schwartz, F. 2010). 
Incorporating physical and emotional care for patients with T2DM enables treating 
clinicians to improve the management of their diseases (Egede & Ellis, 2010). Because 
depression and diabetes have a bidirectional relationship, proper T2DM depression screening and 
treatment are essential to improving the disease management of individuals with T2DM 
(O’Connor, Crain, Rush, Hanson, Fischer, & Kluznik, 2009). Due to the absence of depression 
screening by medical professionals treating individuals with T2DM, clinicians do not diagnose 
patients during the earlier stages of depression (Pouwer, 2017). Disease management is 
compromised for individuals with T2DM because of the lack of depression screening for these 
patients (Culman et al., 2013). 
Clinicians and Comorbid Depression Screening 
Chronic illness is a condition that lasts for years and usually cannot be cured entirely. 
Individuals with a chronic illness can develop depression feelings because of the life disruption 
the illness may cause. Some chronic illnesses are controllable through diet, exercise, and 
medication. For example, chronic illnesses include heart attacks, coronary artery disease, 
Parkinson’s disease, multiple sclerosis, cancer, and diabetes. People with prolonged illness 
develop depression, which is one of the standard complications. Depression triggered by chronic 
illness often worsens the ailment, especially if the illness causes pain and fatigue, or limits a 
person’s ability to interact with others (Simon, 2001). 
Research on prolonged illnesses and depression suggests that depression frequencies are 




attack, who develops coronary artery disease without having a heart attack, develops Parkinson’s 
disease or Multiple Sclerosis, or individuals with cancer and diabetes can exhibit signs of 
depression (Simon, 2001). Presently there are standards of care for treating a chronically ill 
individual for depression. Individuals with chronic disease rely on their clinicians to assist with 
maintaining their health. Clinicians recognize symptoms of depression; believing that anyone 
with a chronic illness could be depressed (Simon, 2001).  
Clinician’s Attitudes toward Screening T2DM Individuals for Depression 
It is essential to understand clinicians’ attitudes toward depression screening for 
individuals with T2DM and why clinicians may or may not screen for depression. This study 
could promote social change by providing an understanding of clinicians’ attitudes and behaviors 
concerning screening patients with T2DM for depression. This study could lead to improving 
depression screening in this population by resulting in  individuals with T2DM receiving the 
psychological care they may need while enduring this chronic illness. 
In a study conducted by Yu et al. (2010), depressive tendencies were apparent in many T2DM 
patients, however, these tendencies were not acknowledged by healthcare workers. Due to the 
link between depression and T2DM, adequate testing would assist physicians in the management 
of patients with T2DM by managing concurrent depression (Acee, 2010). According to de Vries 
McClintock, Boyle, Rooney, and Bogner (2016), an integrated care intervention employing 
patient-prioritized planning that incorporates financial, social, and emotional needs of primary 
care patients with T2DM depression may be useful. Similarly, patients need unique and effective 




Healthcare teams should develop the ability to efficiently and accurately diagnose 
individuals with T2DM for depression instead of labeling them as non-compliant patients 
(Culman et al., 2013). Psychosocial and self-management barriers include depression, adherence 
to prescription regimens, and dramatic lifestyle changes (Raval, Dhanaraj, Bhansali, Grover, & 
Tiwari, 2010). Another barrier includes biological factors such as hormonal changes, lack of 
time, and insufficient social support (Bayliss, Ellis, & Steiner, 2007). Psychological attributes 
relate to significant barriers that patients with T2DM must address for this chronic disease. 
Diabetes presents a challenge for individuals with T2DM because they are overwhelmed by the 
time they are required to self-manage, which causes frustration (Chlebowy, Hood, & LaJoie, 
2010). Difficulties in maintaining the diabetes health-behavior schedule is another challenge for 
individuals with T2DM (Chlebowy et al., 2010). 
Healthcare workers often do not recognize depression among individuals with T2DM 
(Schram et al., 2009); therefore, patients with T2DM are not treated or screened for depression 
during routine medical checkups by their physicians. Clinician acknowledgment and depression 
management may be particularly crucial for older adults with T2DM (Kimbro et al., 2014). 
Using depression screening tools, such as a Patient Health Questionnaire (PHQ-8 or PHQ-2), can 
be an efficient way to recognize depression before it results in an unnecessary health risk that 
may lead to mortality (Kimbro et al., 2014). Undiagnosed depression reasons include physicians’ 
lack of specific training to perform psycho diagnostic interviews (Culman et al., 2013). 
Clinicians who lack knowledge of atypical depression symptoms lack psychological 
expertise and knowledge of proper depression screening tools for diagnosing T2DM depression 




a stigma related to mental illness; clinicians may believe that depression is a normal process in 
aging; furthermore, physicians and nurse practitioners may believe that antidepressants interfered 
with the treatment of other health conditions or interact with other medications. When clinicians 
believe that overlapping symptoms from other chronic diseases explain depression symptoms, 
other chronic health conditions take priority during a short medical visit, (Beverly et al., 2011).  
Path analysis proposes a reciprocal relationship between depression and functioning 
(Schmitz, Gariépy, Smith, Malla, Boyer, Strychar, & Wang, 2013). An example of this is a 
decline in functional independence. Psychological and physical changes, along with life stressors 
can increase allosteric weight, which may support the development of depression. Patients with 
T2DM should obtain an accessible healthcare provider network that includes an endocrinologist, 
psychiatrist, and psychologist (Bensbaa, Agerd, Boujraf, Araab, Aaloiane, Rammouz, & Ajdi, 
2014). Individuals with T2DM could benefit from meeting with a therapeutic staff aware of the 
possible psychological problems while providing diabetes treatment. Targeting diabetes distress 
and depression may improve the outcome of psychosocial intervention approaches in the T2DM 
population (Carper, Traeger, Gonzalez, Wexler, Psaros, & Safren, 2014). 
Clinician Depression-Screening Behaviors 
Clinicians recognize diabetes and depression, but do not relate to screening the 
population for mental health distress (Heckbert et al., 2010). Furthermore, clinicians who 
understand how to use an integrated approach to treating T2DM may offer patients support to 
control their chronic illness (Leone, Coast, Narayanan, & de-Graft Aikins, 2012). It is essential 
to establish criteria for adequate treatment for individuals with T2DM suffering from depression, 




in patients with T2DM (O’Connor et al., 2009). Despite the potential adverse effects of 
psychological health problems on diabetes outcomes and healthcare expenses, only about 1/3 of 
patients with these coexisting illnesses obtain a diagnosis and treatment. 
Physicians and nurse practitioners face challenges when treating T2DM patients’ 
psychological and emotional complications (Ducat et al., 2014). Some clinicians report trouble 
identifying patients’ emotional complications. The absence of psychological expertise 
contributes to clinicians feeling frustrated, inadequate and overwhelmed during T2DM treatment. 
In the study conducted by Ducat et al. (2014), physicians remarked on the stress and anxiety of 
struggling to adhere to a typical medical visits time limitation. Clinicians may benefit from a 
multidisciplinary team approach because the physician’s patient time per visit is limited. A 
multidisciplinary team approach would relieve clinicians of the emotional and social difficulties 
of assessing patients with T2DM (Ducat et al., 2014). The clinicians are challenged when 
treating the social and emotional difficulties of patients with T2DM in order to develop essential 
programmatic interventions (Beverly, Hultgren, Brooks, Ritholz, Abrahamson, & Weinger, 
2011). The deficiency of psychological expertise contributes to doctors feeling frustrated, 
inadequate and overwhelmed. Understanding how clinicians perceive the severity and 
consequences of patients’ psychosocial and mental illness is critical for developing solutions for 
these problems (Beverly et al., 2011). 
It is critical to integrate psychological screening and treatment into a multidisciplinary 
diabetes care team’s work to improve patient and public health outcomes and lessen healthcare 
costs. Depression scales that monitor depressive symptoms are practical in clinical diabetes 




strategies include considering all possible aspects that may contribute to the deterioration of 
diabetes comorbidities (Prabhakar, Gupta, Kanade, & Radhakrishnan, 2015). Individuals with 
T2DM face the stress of long-term therapy associated with diabetes complications. T2DM 
complications include nephropathy, neuropathy, retinopathy, forced lifestyle modifications, and 
prolonged hospitalization periods, all of which may contribute to depression (Prabhakar et al., 
2015). Depression is extremely high in patients with T2DM (Siddique, Dogar, Malik, Haider, 
Afzal, Cheema, & Azeem, 2014). Diabetes Mellitus (DM) increases among those who take oral 
hypoglycemic medications rather than insulin therapy alone. Risk factors for diabetes depression 
should be used to educate doctors treating patients with DM (Siddique et al., 2014). 
Practical management of depression has improved individuals’ quality of life with T2DM 
(Siddique et al., 2014). Treatment strategies for the T2DM population should include the 
physician providing a multifaceted approach, considering all possible elements that may add to 
the intensification of diabetes comorbidities (Prabhakar et al., 2015). Individuals with T2DM 
need continuous monitoring of depression, and once identified, should be required to maintain an 
excellent prognosis for diabetes and related complications, including mood disorders like 
depression. 
The Effects of Peer-Influence Between Clinicians 
According to Yang, Lien, and Chou (2014), research revealed that peer-influences are 
small between doctors, and stronger among physicians of similar age. Social learning can impact 
physician peer-influence as a process in which decision makers collect information by observing 
others in their social network (Yang et al., 2014). Through this process, individuals’ behaviors 




peer-effects can be detected and revealed by changes in an individual’s behavior in response to 
that of his or her peers. The peer-effect study found that positive peer-effects are more likely to 
exist when peers are of similar age, presumably having similar, comparable experience and 
background (Yang et al., 2014). Peer-effects were stronger when physicians have direct 
interactions with their colleagues through observations or conversations. It implies that 
promoting medical innovations or new scientific findings beneficial to society can be most 
effective when the new drug, technology, device, or practice is first introduced (Yang et al., 
2014). 
Patient Health Questionnaire (PHQ-9) Scale 
The Patient Health Questionnaire (PHQ-9) is a valuable instrument for screening Type 2 
Diabetes Mellitus (T2DM) for depression in a primary care setting (Bogner & de Vries, 2010). 
The PHQ-9 is a questionnaire that scores each of the nine criteria listed in the Diagnostic and 
Statistical Manual of Mental Disorders for depression with scores ranging from 0 to 3 (Locke, 
Kirst, & Shultz, 2015). PHQ-9 scale scores indicate a sensitivity of 88% if the score is ≥ 10 and 
establishes significant depression. PHQ-9 scale scores of 5, 10, and 20 represent mild to severe 
depression (Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., … 
Hatcher, 2010). The U.S. Preventive Service Task Force supported using PHQ-9 scales for 
depression screening for individuals with T2DM in a primary-care setting (Egede & Ellis, 2010). 
Patients can complete the PHQ-9 scale quickly during an office visit. Primary care 
physicians can educate ancillary health personnel, such as licensed practical nurses, to administer 
the test to T2DM patients (Bogner & de Vries, 2010). The PHQ-9 has a scoring scale to 




source that can ascertain the effectiveness of depression treatment over time (Acee, 2010). 
Individuals with T2DM depression need identification as soon as possible. 
Providing the medical community with an understanding of the psychosomatic, 
emotional, and social impact of diabetes depression would improve the prognosis for individuals 
with T2DM (Speight, Browne, Holmes-Truscott, Hendrieckx, & Pouwer, 2012). Diabetes 
promotion and prevention screening focus on reducing diabetes depression and promote positive 
health habits. Also, it enhances health and well-being in populations (Nelson & Prilleltensky, 
2005). The study conducted by Gois, Dias, Carmo, Duarte, Ferro, Santo, Sousa and Barbosa 
(2014) revealed that interpersonal Psychotherapy is a useful tool to treat major depression in 
T2DM patients.  
Summary 
Social change is a continuing process of improving and introducing positive changes. 
Continually examining disease symptoms would help to improve the quality of life globally. 
Individuals with Type 2 Diabetes Mellitus risk depressive moods resulting in physicians 
prescribing a high percentage of antidepressant agents (Whittemore, Melkus, & Grey, 2004). 
Individuals with DM are unaware that they have developed depression and are unlikely to seek 
medical care for depression (Campayo, de Jonge, Roy, Saz, Camara, Quintanilla, & Lobo, 
2010). Publicly, a need persists to increase depression awareness, depression screening, and 
initial identification of depression conditions in individuals with T2DM during healthcare 
treatment (Schram et al., 2009). 
Currently, depression is unrecognized among individuals with diabetes. Beginning a 




depression and early initiation of treatment for depression could reduce the worldwide burden of 
depression among individuals with diabetes (Egede & Ellis, 2010). A psychosocial assessment 
should be part of the regular clinical evaluation of patients with T2DM (Sweileh et al., 2014; 
Thour, Das, Schrawat, & Gupta, 2015). Screening patients with T2DM should occur at primary 
healthcare clinics to improve patients’ quality of life and decrease adverse outcomes. It is 
essential to understand clinicians’ attitudes toward depression screening for individuals with 
T2DM and why they may or may not screen for depression. 
Chapter 3 addresses the methodology and research design used in this research; Chapter 4 
explains the results of this study; and Chapter 5 provides an interpretation of the findings and 




Chapter 3: Research Method 
Introduction 
This qualitative descriptive-design study used a case study approach to understand 
clinicians’ perceptions of screening patients with T2DM for depression, as well as examine their 
behaviors regarding screening. In this chapter, the sample size and eligibility criterion for the 
case study is discussed. Also, a description of the significant components of the methodology 
used in this analysis includes (a) the research design and rationale, (b) the role of the examiner, 
(c) the method, (d) issues of reliability, and (e) a summary. This chapter also includes a 
description of the instrumentation and materials to be used. 
Research Design and Rationale 
A qualitative study is a means to explore and understand the meaning individuals or 
groups ascribe to human problems (Creswell, 2014). The inquiry process involves asking 
emerging questions and processes; assembling data in a relevant setting; analyzing the data 
inductively, building from particulars to general themes; and translating the data’s meaning. 
Creswell (2009) recommended that qualitative researchers choose from among the possibilities, 
such as a case study. Case studies align with the qualitative design and are widespread across the 
health sciences for conducting research. A case study design can focus on a particular subject or 
individual case (Creswell, 2009). Case studies are the tactic of inquiry. In this case study, I 
comprehensively explored programs, events, activities, and processes of several individuals. 
Case studies are limited by time, activity, and the researcher’s ability to collect detailed 
information using various data-collection procedures over a sustained period (Creswell, 2007). I 




The essential questions of this research were:  
1. How do physicians and nurse practitioners describe their attitudes toward screening 
T2DM patients for depression? 
2. How do physicians and nurse practitioners describe their T2DM depression –
screening behaviors? 
3. How do physicians and nurse practitioners describe their perceptions of whether their 
peers support screening the T2DM patient for depression? 
The following are an example of research questions that were asked during the interview: 
1. Do you talk to your Type 2 Diabetic patients about depression? 
a) If yes, please describe your process for talking with your patients. 
b) If no, please describe why you did not discuss depression with your patients. 
2. Do you screen T2DM patients for depression? 
a) If yes, please describe your process for screening T2DM patients for depression. 
b) If no, please describe why you do not screen T2DM patients for depression. 
3. What do you think are the advantages and disadvantages of screening T2DM patients 
for depression? 
4. Do you think your peers would approve of screening T2DM patients for depression? 
a) Describe what you think your peers think about screening T2DM patients for 
depression. 
The case study research uses a qualitative approach (Creswell, 2007). Researchers 
explore a limited system (a case) or multiple systems (cases) over time through detailed, in-depth 




anthropologists, and sociologists use a case study approach, and it is a simplified methodology in 
psychology and medicine when analyzing specific problems (Creswell, 2007). The rationale for 
selecting this design relates to this study’s purpose: understanding clinicians’ perceptions of 
screening patients with T2DM for depression, as well as examining their behaviors regarding 
testing for depression (Ajzen & Fishbein, 1980). 
Stake’s (2006) most recent book on multiple case study analysis presents a step-by-step 
approach and illustrates numerous case studies in Ukraine, Slovakia, and Romania. A case study 
is a good plan when the inquirer has an identifiable question. The case study has boundaries and 
provides an in-depth understanding of the case or a comparison of several cases (Creswell, 
2014). According to Creswell (2007), case study research should include no more than four or 
five case studies in a single study. This number has offered ample opportunity to recognize 
themes of the cases as well as to conduct cross-case theme analysis (Creswell, 2007). Case 
studies are standard in the medical field to investigate or search for understanding of a group of 
medical professionals’ behavior and psychosocial impact.  
Role of the Researcher 
A qualitative study requires a small number of individuals or situations that preserve the 
individuality of each of these in their analyses, rather than collecting data from large samples and 
aggregating the data across individuals or situations. My role as a researcher was to understand 
and explore cases for T2DM depression. I was required to ensure that the interviews were 
conducted thoroughly. It was my responsibility to ensure that participants understood the 
investigation questions, felt comfortable discussing the study, and were encouraged to exhaust 




role was to eliminate any situation of conflict of interest. Also, it was my responsibility to ensure 
that the interview process was unbiased. To the best of my ability, I conducted and analyzed the 
study without any prejudgment or preconception.  
My role as the researcher was to determine if the participants were appropriate to 
participate in the study by reviewing the participant’s medical practice history. The participant 
must have had a state medical license and specialty medical license, treat T2DM subjects, and 
had been in practice for 5 years. Also, all data were collected from the participants in their 
natural environment. In the researcher’s role, I viewed myself as a human instrument, gathering 
data from participants through interviews, tape recordings, and field notes. Data were collected 
by asking participants interview questions about their clinic and patient population. I recorded 
participants’ answers during the interview sessions, and after data collection, I analyzed 
participants’ answers. 
Methodology 
The study participant recruitment took place in Saint Louis, Missouri, and the following 
cities in Mississippi: Charleston, Horn Lake, Calhoun City, Pora, Hernadoi, and Pope. Doctors 
and nurse practitioners had agreed to confidentiality prior to the study. Participants had ample 
time to address protocol questions. I obtained protocol approval from Walden University’s 
Institutional Review Board (IRB) before the study began, and I maintained current documents 
and fulfilled all IRB requests during the study. 
Recruitment began by contacting medical schools and the medical society, reviewing the 
phone book and the internet in Saint Louis, Missouri, Charleston, Horn Lake, Calhoun City, 




letter by email to introduce the study to physicians and nurse practitioners requesting their 
participation in the study. Advertising of the study did not occur, I recruited doctors and nurse 
practitioners through email and telephone contact. All physicians and nurse practitioners’ legal 
qualifications were verified thoroughly by the Missouri and Mississippi Medical-License Board. 
The Missouri and Mississippi board of registration has a list of licensed clinicians, including 
their license number, license expiration date, primary business address, board certification, and 
professional school. 
Recruited participants were expected to speak and read proficiently in English. 
Participants consisted of five to ten doctors or nurse practitioners with a medical license. 
According to Creswell (2007), case studies require five to ten cases for a single research study. 
Doctors and nurse practitioners were required to have at least 5 years of experience and actively 
be treating patients diagnosed with T2DM. I collected the doctors’ and nurse practitioners’ 
demographics and education level during the interviews for sample-description purposes only. 
All eligible clinicians who gave informed consent were the participants interviewed for this 
study. I explained the participants’ rights during the informed-consent process. Doctors and 
nurse practitioners had the right to refuse participation without any penalty. Participants verbally 
consented prior to completing any study procedures or interviews. The Interview Questions 
Guide directed interviews so that participants discussed matters related to screening patients with 
T2DM for depression. I interviewed 8 clinicians for this T2DM study, and this sample size 
achieved saturation of themes. Saturation is achieved once the interviewer has no new data to 





The qualitative research instrumentation used in this study included interview questions 
and observations. The open-ended interview questions allow me to focus on the individual and 
provide the opportunity for a detailed investigation of participants’ perspectives and an in-depth 
understanding of the personal context within which the investigation was conducted (Schensul, 
Schensul, & LeCompte, 1999). Interviews were conducted via telephone or privately online 
using email. I asked all participants for one hour of their time to answer open-ended questions. 
An Interview Guide (Appendix A) was used to manage the flow of the interview. The questions 
in the Interview Guide reflect the literature gap and focus on the objectives of the study. The 
Interview Guide helped me pursue the same primary lines of inquiry with each participant. Focus 
groups were not considered for this study because they do not focus on the individual, and they 
employ less opportunity for the generation of individual accounts. 
Procedures 
Study research questions were addressed through open-ended, and in-depth interview 
questions. Questions were administered to informants via telephone in the participant’s office or 
the setting of choice. The primary data source was collecting a narrative recording of 8 
participants. Before each interview, participants were requested to agree to a digital record of the 
conversation. I interviewed participants via telephone and used email for those participants who 
cannot meet with me in person. Through email, I communicated with participants in writing. The 
email allowed me to save written conversations to a new external drive.  
I sent qualified and interested participants information about the study, participation 




written consent during email or verbal consent during telephone interviews. I asked participants 
to provide compatible days and times for scheduling a 60 minutes telephone interview and gave 
basic instructions on how to access Skype if they did not have it installed on their computers. 
Participants could opt to have a Skype interview instead of a telephone interview. 
To assist participants, I sent the interview questions prior to the interview. The interview 
(see Appendix A) began by asking, “Do you treat patients with T2DM in your practice?” Next, I 
asked participants about their treatment and screening behaviors. The complete interview 
protocol appears in Appendix A. I developed the interview questions after referencing work by 
Ajzen and Fishbein (1980). The interview questions were not pilot tested. 
All study-related data and material will be maintained for a minimum of 5 years after 
completing the research. I identified each participant by their name and I randomly assigned each 
participant a number to conceal their identity. I recorded all participants’ telephone conversations 
during the interview. The participants’ information collected was summarized for the participant 
during the interview to agree or disagree with the information and I transcribed the interview 
summary afterward for analysis. I sent a $10.00 Starbucks gift card thanking respondents for 
participating approximately five to ten days after each interview. Member checking was used to 
check the accuracy of the transcriptions. 
Data-Analysis  
The data-analysis techniques included describing, interpreting, drawing conclusions, and 
determining significance. The emergence of findings through my interaction with and 
involvement in the data results in the form of patterns, themes, or categories that emerge from 




saying without bringing any preexisting codes. The participants’ summary and digital record of 
the conversation was transcribed before the data were analyzed. Open coding emphasizes 
recognizing any patterns that emerge from the data. The coding process involves reviewing the 
data, applying short-hand labels to passages of data, or other items for more natural organization 
and recognition. 
The next step in case study data analysis was comparing across various themes that have 
emerged from the data as well as making comparisons across cases; I compared themes as they 
emerge. I used the data to create detailed descriptions of clinicians’ screening or not screening 
patients with T2DM for depression. I used NVivo to analyze the data for the case study. NVivo 
is software that supports qualitative and mixed-method research. NVivo is a computer program 
designed to help organize and discover a comprehension of unstructured or qualitative data like 
interviews and open-ended survey responses. NVivo analyzes small or large volumes of data and 
is available for Windows PCs. NVivo helps researchers analyze and manage qualitative data, 
allowing for the researchers to manipulate the data, codes, and categories in the data (Creswell, 
2007). 
Manually analyzing data could be time-consuming, challenging researchers to manage 
and navigate the process. Completing this kind of research without software can make it 
challenging to discover connections in the data and find new insights. I managed data analysis 
using NVivo software, identifying themes that describe if and why clinicians screen for 




Issues of Trustworthiness 
The issues of trustworthiness were established by credibility, transferability, 
dependability, and confirmability (Rudestam & Newton, 2007). Researchers use this process to 
determine whether the participants report accurate information. Credibility in qualitative research 
corresponds with internal validity. The study findings’ credibility requires sufficient time with 
the participants to check for distortions, explore the participants’ experience, and lack details. 
The extended time was spent to help develop an in-depth understanding of the study, which can 
convey details about the site and the people that lend credibility to the narrative description.  
Transferability in qualitative research corresponds with external validity (Morrow, 2005). 
External validity would allow the researcher to duplicate the original study design process and 
apply it to other studies. The qualitative study was a description of a relatively small number of 
participants within the context of a specific setting. The study participants’ qualitative 
descriptions or settings were sufficient and can be applied in a similar setting. Generalization is 
the reader’s task rather than the author of qualitative studies (Rudestam & Newton, 2007). 
Dependability in qualitative research corresponds with reliability (Morrow, 2005). 
Surveys and interviews were part of the internal validity which obtains information from the 
participants (Rudestam & Newton, 2007). Internal validity includes scientific observations and 
measurements (Rudestam & Newton, 2007). Dependability would allow the results of the survey 
to be duplicated.  
Confirmability in qualitative research corresponds with objectivity (Rudestam & Newton, 
2007). Purposeful sampling has a means by which qualitative researchers increase credibility. I 




was enhanced by using original data; making it available to interested readers, and keeping an 
ongoing journal of the experience. I provided questions, interpretive processes, document 
activities, and discussion with participants to interest readers (Rudestam & Newton, 2007). 
Ethical 
The ethical protection includes the participants’ rights, risks, and confidential information 
about the subject’s study results (Creswell, 2014). The rights, risks, and confidentiality of the 
participants were explained during the informed consent process. The participants were notified 
of their rights during the informed consent progress. The participants had ample time for 
questions and answers about the study. The participants’ risks include social, economic, physical, 
and psychological harm, which could occur during or after the study. The social risk could 
include jeopardizing the individuals’ reputation and social standing.  
Summary 
This section discussed data-collection and analysis protocols for the study. I presented a 
brief discussion of the qualitative methodology. My role as the researcher which was to 
interview participants, record answers, and analyze the data. The segment on participants 
contained the required criteria for participation and presented the advantages and disadvantages 
of internet use for data collection. Sections on data collection and analysis discussed how data 
were obtained and used, including activities to enhance rigor and legitimacy. Chapter 4 presents 




Chapter 4: Results 
Introduction 
This qualitative case study explored attitudes, behaviors, and perceptions of physicians and 
nurse practitioners treating individuals with T2DM. Specifically, the purpose of the study was to 
explore the physicians’ and nurse practitioners’ screening of patients with T2DM for depression, 
as well as their thoughts and behaviors regarding screening. Through a systematic sampling 
methodology, ten participants were interviewed. The following research questions guided this 
study:   
Research Question 1: How do clinicians describe their attitudes toward screening T2DM 
patients for depression? 
Research Question 2: How do clinicians describe their T2DM depression –screening 
behaviors? 
Research Question 3: How do clinicians describe their perceptions of whether their peers 
support screening the T2DM patient for depression? 
In this chapter, I discuss the setting, demographics, data collection, data analysis, and 
results. The data analysis subsection includes a description of the 10 codes that emerged from the 
data and contributed to the thematic analysis. I then discuss evidence of trustworthiness, which 
includes addressing credibility, transferability, dependability, and confirmability of the data. 





After obtaining IRB approval (#10-03-18-0071106), I contacted clinicians through their 
publicly available hospital email or telephone number to solicit their participation. Additional 
participants were obtained through the snowball method.  
After ascertaining that each participant met the eligibility criteria, including that of 
specializing in treatment of T2DM, the study interview took place using the interview questions 
presented in Appendix A and discussed in Chapter 3. Follow-up questions were asked in 
interviews if necessary to better understand what the participant raised. The interviews took 
place in a quiet space with a closed door to allow for privacy and no interruptions. No personal 
or organizational conditions influenced participants during the interview at the time of the study.  
Demographics 
A total of 11 participants were recruited to the study; however, three of the participants recruited 
were not included due to insufficient years of experience treating individuals with T2DM and 
thus not meeting study eligibility. Three doctors and five nurse practitioners took part in the 
research. The participants all spoke English, had 5 or more years of experience treating 
individuals with T2DM, and had a medical license in the United States. Participants were 
between the ages of 30 to 70, with one being between the ages of 30 to 39; four were between 
the ages of 40 to 49, and three were between the ages of 60 to 69. Six of the participants were 
female. All participants were married, except one, who was widowed. Three participants were 

















Participant 1 60-70 Male Married Endocrinologist 20+ Unknown 
Participant 2 40-50 Female Married Internal Medicine 15+ 41+ 
Participant 3 40-50 Female Married NP general medicine 20+ 31-40 
Participant 4 60-70 Male Married Endocrinologist 20+ Unknown 
Participant 5 30-40 Female Married NP general medicine 10+ 21-30 
Participant 6 40-50 Female Married NP family medicine 10+ 06-10 
Participant 7 60-70 Female Widowed NP family medicine 05 21-30 
Participant 8 40-50 Female Married NP general medicine 20+ 21-30 
 
Data Collection 
I collected data from 8 medical professionals using the method described in Chapter 3 
with some approved revision, explained below. Each participant consented and had ample time 
to ask questions if needed. I collected demographic and descriptive information during the 
interview from physicians and nurse practitioners. It included age range, education, marital 
status, type of physician or nurse practitioner, office setting, years of experience treating T2DM 
patients, and number of T2DM patients seen in a day (see Appendix D). I interviewed each 
participant 30-60 minutes one time and summarized their responses during the discussion. The 
interviews took place in a quiet space of the participant’s choice with a closed door to ensure 




Participants’ interviews were recorded on a digital recording device, and hand-written notes were 
also taken during the interview. The digital recording and notes were checked after the 
transcribed data were analyzed to establish credibility. No unusual circumstances arose during 
data collection interviews. 
The data collection differed from the original plan in Chapter 3 to include a nationwide 
search for participants, and the search was extended to include nurse practitioners. The original 
data collection plan only included Missouri physicians. However, due to the inability to recruit a 
sufficient number of physicians for the study in Missouri, I submitted a request form to the IRB 
for recruitment to be extended nationwide and to include nurse practitioners in addition to 
physicians. The original research questions were adjusted to include both physicians and nurse 
practitioners. 
Data Analysis 
In this study, I captured the perceptions and experiences of participants screening T2DM 
patients for depression. Once the interviews were complete, I read the transcribed data multiple 
times while listening to the digital recording to ensure accuracy and began the process of 
identifying codes and themes that emerged from the data. I put the information into NVivo, 
arranging the data to establish codes and themes. The data analysis strategy included the steps I 
outlined in Chapter 3.  
First, I recorded and transcribed each interview. I highlighted significant statements of 
how participants described their experiences and entered the data information into NVivo. The 
next step included developing codes and themes. A written account of what participants 




composed. A written summary of the position or opinion of participants’ experiences treating an 
individual with T2DM depression was developed into themes. The following are the codes that 
emerged, along with short definitions and examples of direct statements taken from the 
interviews with study participants that demonstrated each code meaning. Ten codes emerged 
from the data includes.  
1. Sleep Deprivation supported by 10% of the participant. 
2. Scale Patient Health Questionnaire 2 Item (PHQ-2) supported by 10% of the 
participant. 
3. Scale Patient Health Questionnaire 9 Item (PHQ-9) supported by 20% of participants. 
4. T2DM Depression Screening supported 20% of participants.  
5. Diabetic Diet supported by 10% participants.  
6. T2DM Depression Non-Screening supported by 20% participants.  
7. Peer Approval supported by 50% of participants. 
8. Advantage of Depression Screening supported by 20% of participants.  
9. Focus supported by 40% of participants.  
10. Standard of Care supported by 40% of the participants.  
Three themes emerged from the codes to answer research questions.  
Code 1: Sleep Deprivation 
Sleep deprivation emerged in the data referring to any sleep deprivation or disruptions 
due to T2DM. The sleep deprivation was described as symptoms of sleep fragmentation and 





Code 2: Scale Patient Health Questionnaire 2 Item (PHQ-2) 
The code PHQ-2 emerged when a participant described the screening process of 
individuals with T2DM. The PHQ-2 is a scale that measured the frequency of an individual’s 
depressed mood over the past 2 weeks. The code PHQ-2 refers to tools used to evaluate T2DM 
patients for depression during a clinic visit. Participant 2 contributed the PHQ-2 code. 
Code 3: Scale Patient Health Questionnaire 9 Item (PHQ-9)  
The code PHQ-9 emerged when a participant described the screening process of 
individuals with T2DM. The PHQ-9 is a scale that screens, diagnoses, monitors, and measures 
the severity of an individual depressed mood. Participants 2 and 8 contributed to the PHQ-9 
code. 
Code 4: T2DM Depression Screening  
The code T2DM Depression Screening emerged when a participant described any 
screening process of individuals with T2DM. The T2DM Depression Screening code was 
described as mood and mental changes causing depression in individuals with T2DM. 
Participants 2 and 8 contributed to the T2DM depression screening code. 
Code 5: Diabetic Diet  
The code Diabetic Diet emerged when a participant described the diet, eating, or anything 
related to a dietary plan in T2DM patients. Participant 3 contributed the T2DM diabetic diet 
code. 
Code 6: T2DM Depression Non-Screening 
The code T2DM Depression Non-Screening emerged when a participant described the 




was defined as deliberate non-screening of depression in patients with T2DM. Participants 2 and 
8 contributed the T2DM depression non-screening code. 
Code 7: Peer Approval 
The code Peer Approval emerged when the participants talked about their perception of 
what their peers thought about screening or peers’ behaviors regarding screening. It was a 
perceived positive appraisal of screening by their peers. Participants 2, 5, 6, 7, and 8 contributed 
to the T2DM peer approval code. 
Code 8: Advantage of Depression Screening 
The code advantage of depression screening emerged when participants described the 
benefits of screening for depression in their patients. Participants 2 and 8 contributed the 
advantage of the depression screening code. 
Code 9: Focus  
The code Focus emerged when participants described their emphasis on treating the 
patient’s diabetes. Clinicians were not focusing on the comorbidity of patient diabetes disease. 
Participants 3 and 5 contributed the focus code. 
Code 10: Standard of Care 
The code Standard of Care emerged when the participants described a standard of care 
for T2DM patients. Participants 2 and 8 contributed the T2DM standard of care code. 
The codes of Focus, Standard of Care, and Peer Approval, rolled over into the theme 
category to answer the research questions. Overall, three themes emerged from the data to 
explain physicians’ and nurse practitioners’ experiences of screening T2DM patients for 




diabetes and not the comorbidity of the disease, 2) T2DM depression screening standard practice 
or part of the clinical assessment process, and 3) peer’s approval of T2DM depression screening. 
Each theme is discussed in conjunction with the relevant research question below.  
Results for Research Question 1 
Research Question 1 asked: How do physicians and nurse practitioners describe their 
attitudes toward screening T2DM patients for depression? One theme emerged to answer this 
question. The first and most dominant theme that emerged from interviews and the theme that 
provides data for this research question was that physicians and nurse practitioners believed their 
focus as a clinician was to treat the physical disease of diabetes, with little attention given to 
psychological or social conditions. Although clinicians acknowledged depression as comorbidity 
of diabetes, clinicians talked extensively about treating T2DM and their primary focus on the 
patient's physical disease.  
It was evident from four clinicians’ statements that the physical illness was the focus of 
most of their time with their patients. For example, when discussing what they focused on 
regarding treatment, clinicians often discussed diet. Participant 3 reported that “patients are 
encouraged to eat less rice, less bread, and encourage healthier foods (for example, green leafy 
food) and exercise.” Furthermore, participant 5 stated, “patients are encouraged to lose weight 
and not to use food as a comfort.” Some patients were prescribed diabetic medication because of 
weight gain and serum blood sugar increase. In discussing their attitudes towards screening 
T2DM patients for depression, it was clear that participants primarily focused on diabetes 




It should be noted that interviews revealed that clinicians were aware that depression was 
a comorbidity of individuals with T2DM. Most of the clinicians also reported that they had a 
standard care protocol for screening T2DM patients for depression as part of the routine visit. 
However, according to the clinicians' statement, depression was not a primary focus of treating 
patients with T2DM depression, but rather the clinicians focused on physically controlling 
T2DM patients' blood sugar.  
Therefore, a dominant theme of the interviews was the focus on the physical treatment of 
depression, and while it should be noted that most of the physicians and nurse practitioners did 
screen for depression, they did not consider it a focus of their attention. They were aware of 
depression’s comorbidity with T2DM and also acknowledged its importance. However, they did 
not perceive it to be their focus. The participants’ screening behaviors are noted in the 
description of findings under Research Question 2. 
Results for Research Question 2 
Research Question 2 asked: How do physicians and nurse practitioners describe their 
T2DM depression –screening behaviors? A standard of care theme emerged to answer this 
question. The second and most dominant theme that emerged from interviews, and the theme that 
answered this research question, is that physicians and nurse practitioners believed their standard 
of care addresses depression screening of patients’ T2DM during routine diabetes checkup. 
Although clinicians acknowledged depression as a comorbidity of diabetes and did have a 
screening protocol as part of routine visits, few clinicians talked about depression with their 




mental health during the routine diabetic examination in their office. If [the participant] identifies 
a patient with depression, then the patient is treated with medication for the depression. 
Additionally, participant 4 stated that they provide “a brief discussion with T2DM 
patients about depression”. However, they went on to say that further details would be explored, 
if necessary, with little specificity of what that looks like. Participant 6 stated that “asking the 
T2DM patients if they are feeling unhappy is how patients are evaluated for depression.” 
Participant 1 described that “the depression screening process for T2DM patients occurs during 
annual checkups by administering the PHQ-9 scale if the patients are over 65 years of age. If the 
T2DM patient has a depression diagnosis, then the primary care physician treats the patient for 
T2DM and depression.” 
From their discussion of depression screening behavior of T2DM patients for depression, 
it was clear that participants’ standard of care technically addresses an individual’s mental status 
with diabetes, but with little focus provided or developed. This reinforces the theme focus found 
in Research Question1 in which clinicians’ focus is on physical disease management.  
Results for Research Question 3 
Research Question 3 asked: How do physicians and nurse practitioners describe their 
perceptions of whether their peers support screening the T2DM patient for depression?  The third 
theme that emerged from interviews is that physicians believed their peers would support 
screening T2DM patients for depression. According to Participant 2, “[their] peers would support 
screening T2DM for depression and would say that treating the patient’s mental health was 
essential.”  Participant 2 also stated that, “the American College of Medicine recommends 




[their] peers are screening T2DM for depression, [their] clinic would evaluate if that was 
something to incorporate into [their] clinic”. In their discussion, Participants 2, 5, 6, 7, and 8 
stated that they understood the benefit of screening T2DM for depression, believed it would be 
widely supported, and acknowledged that early detection of depression would allow for 
treatment of depression sooner rather than later. Despite a keen awareness of peer and 
professional organization support for screening for depression in T2DM, with ample evidence 
for its necessity, clinicians continued to focus on being responsible for managing the physical 









Participants Themes Research questions 
1, 3, 4, 5 Focus How do physicians and nurse   
practitioners describe their 
attitudes toward screening T2DM 
patients for depression? Although 
clinicians acknowledged 
depression as a comorbidity of 
diabetes, clinicians talked 
extensively about their focus on 
treating T2DM being primarily 
the patient's physical disease. 
2, 6, 7, 8 Standard of care                 How do physicians and nurse 
practitioners describe their T2DM 
depression –screening behaviors? 
From their discussion of 
depression screening behavior of 
T2DM patients for depression, it 
was clear that participants’ 
standard of care technically 
addresses an individual’s mental 
status with diabetes, but with little 
focus provided or developed. 
2, 5, 6, 7, 8 Peers approval                      How do physicians and nurse 
practitioners describe their 
perceptions of whether their peers 
support screening the T2DM 
patient for depression?  Despite a 
keen awareness of peer and 
professional organization support 
for screening for depression in 
T2DM, with ample evidence for 
its necessity, clinicians continued 
to focus on being responsible for 









Evidence of Trustworthiness 
Credibility 
As noted previously in the methods section of Chapter 3, quality research involves 
validation strategies. According to Creswell (2007), credibility, transferability, dependability, 
and confirmability, are essential to helping solidify the study’s documentation accuracy. This 
qualitative case research study aimed to understand participants’ attitudes, behaviors, and 
perceptions of screening patients with T2DM for depression. The participant is best able to 
determine credibility of the data that they have contributed. Thus, one of the best ways to 
establish credibility is to have participants check the data for accuracy. I provided a summation 
of the participant responses to the interview questions during the discussion, and the participants 
were allowed to agree or ensure correctness, which was the most significant method to verify 
credibility, according to Creswell (2007). This study further addressed reliability of the data 
through the saturation in the information received. 
Transferability 
Transferability was addressed in this study through purposeful sampling. It was further 
addressed through the detailed description of the population and setting. Purposeful sampling is a 
technique widely used in qualitative research to identify and select participants for the most 
effective use of limited resources. Although this study utilized purposeful sampling by requiring 
participants to meet specific criteria, the results may apply to other studies (Rudestam & Newton, 
2007). This qualitative research presented detailed description of the participants, and the study 





Reliability in qualitative research can be seen as dependability in qualitative research 
(Rudestam & Newton, 2007). This research established dependability through the use of auditory 
taped interviews. I reviewed the transcribed audiotapes numerous times to maintain accuracy in 
conjunction with detailed notes of each interview.  
Confirmability  
Confirmability is the degree to which others can confirm the results. Confirmability was 
easily established by documenting the procedures for checking and rechecking the data. I 
summarized the participants’ results during the interview to recheck accounts of their experience. 
Though inter coding reliability may be established through use of two or more coders, this study 
used intra coding with only me. I intra coded systematically to ensure all coding was consistent 
(Creswell, 2007). 
Summary 
This chapter provided the original study results that examined physicians’ and nurse 
practitioners’ attitudes, behaviors, and perceptions, regarding screening T2DM patients for 
depression through three research questions. The results led to 10 codes and 3 theme findings. 
The overall results indicated that participants’ varied in treating T2DM patients. Peer influence 
on screening patients for T2DM, while reported to be positive, appeared to have little effect on 
clinicians. The medical office process appeared to regulate whether individuals with T2DM were 
screened for depression by the clinicians. The clinicians were aware that individuals with T2DM 
could develop depression; however, the majority of the clinicians’ focus in treatment appeared to 










Chapter 5: Discussion, Conclusions and Recommendations 
Introduction 
This qualitative case study was conducted to examine clinicians’ attitudes, behaviors, and 
perceptions in screening individuals with T2DM for depression. A qualitative case study design 
was employed, that allowed for physicians and nurse practitioners to describe their process for 
screening patients with T2DM for depression. While conducting a review of the literature, I 
found limited research that focused on individuals with T2DM and depression. This research 
study was driven by that lack of research and the need to examine attitudes and behaviors of 
clinicians towards screening T2DM patients for depression. Results from this study could add to 
the body of knowledge relating to clinicians and T2DM depression screening.  
In this chapter, I discuss the analysis and interpretation of the findings. I also discuss 
study limitations, recommendations for future research, and implications for social change. 
Clinicians were asked three research questions pertaining to their processes for screening 
T2DM patients for depression. The research questions were as follows: 1) How do clinicians 
describe their attitudes toward screening T2DM patients for depression? Based on participants’ 
responses, I determined that three participants screened patients for T2DM depression as this was 
part of the clinic’s health checkup process; however, the majority of clinicians did not screen 
T2DM patients for depression. 2) How do clinicians describe their T2DM depression screening 
behaviors? Most of the clinicians’ treatment focus appeared to be on the patients’ physical 
management of their disease through diet regimen, medication, and exercise. I also found that 
most participants did not screen T2DM patients for depression or speak with the patient about 




that individuals with T2DM could develop depression. 3) How do clinicians describe their 
perceptions of whether their peers support screening T2DM patient for depression? While peer 
influence on screening patients with T2DM for depression reported to be positive, it appeared to 
have little effect on clinician’s behavior or attitudes towards screening T2DM patience’s for 
depression. 
This qualitative study included eight participants that I interviewed for approximately 30 
to 60 minutes each. Based on the answers to the three research questions, four out of the eight 
participants felt they should start screening T2DM patients for depression. The four stated that 
perhaps depression screening should be added to their clinic screening process for T2DM 
patients. Results led to 10 codes and three theme findings; the overall results indicated that 
participants’ experience varies when treating T2DM patients.  
Interpretations of Finding 
TRA was used as a theoretical lens to explore clinicians’ behaviors related to screening 
T2DM individuals for depression. Three research questions were created to explore phenomenon 
experiences of clinicians’ processes of screening T2DM patients for depression. From the 
interview data, 10 codes and three themes emerged. The overall results indicated that 
participants’ attitudes varied toward T2DM depression screening.  
TRA served as the theoretical framework for this study. Using TRA as a theoretical lens, 
this study explored clinicians’ depression screening behaviors, attitudes toward screening, and 
perceptions of social peer approval toward screening patients with T2DM for depression. The 
study results led to 10 codes and three theme findings. The three themes emerged from the data 




patients for depression. The first theme included clinicians’ focus on treating the physical disease 
of diabetes and not the comorbidity (depression) of the disease, the second theme was T2DM 
depression screening standards of care are part of the clinical assessment process, and the final 
theme was that peers approved of T2DM depression screening.  
The medical office process appeared to regulate if individuals with T2DM were screened 
for depression by the clinicians. The clinicians are aware that individuals with T2DM could 
develop depression; however, most of the clinicians’ focus on treatment appeared to be on the 
patients’ physical management of disease through diet regimen, medication, and exercise. 
Results revealed that clinicians focus primarily on treating individuals with T2DM physical 
disease and ignore T2DM depression. The four clinicians lacking screening individuals for 
T2DM depression could result in clinicians not providing the patient with comprehensive care 
for T2DM diabetes. Providing patients with T2DM, a psychological evaluation for depression, 
and a physical treatment plan could improve this population's overall health.  
I also used TRA as a theoretical lens to explore clinicians’ attitudes toward screening 
T2DM patients for depression. Results revealed that some physicians and nurse practitioners 
have a T2DM standard of care procedure that includes screening individuals with diabetes for 
depression during routine diabetes checkups. Further, clinicians who acknowledged that 
depression is a comorbidity of diabetes have a screening protocol as part of routine visits and 
discuss depression with their T2DM patients during their routine checkups. By screening T2DM 
patients for depression, the physician and nurse practitioners provide the patient with a 




TRA was also used as a theoretical lens to explored clinicians’ perceptions of social peer 
approval toward screening patients with T2DM for depression. Results revealed that clinicians 
believe their peers would support screening T2DM patients for depression. Results indicated that 
clinicians' peers supported screening T2DM patients for depression and felt that treating the 
patient's mental health was essential. The benefit of screening T2DM patients for depression was 
widely supported, and it was acknowledged that early detection of depression would allow for 
depression treatment sooner. Despite a keen awareness of peer and professional organization 
support for screening for depression in T2DM patients and with strong evidence for its necessity, 
clinicians continued to focus on their responsibilities of managing the physical side of the 
disease. Even those clinicians are aware that individuals with T2DM could develop depression. 
Most clinicians focus on the patients’ physical management of disease because that is the 
standard of care for diabetic patients. 
Limitations of this Study 
This research study was limited to a focus on clinicians screening of patients with T2DM 
for depression. This study results do not expand to other chronic diseases. Another limitation was 
that if clinicians understand T2DM depression exists and if they included screening patients with 
T2DM for depression. The completion of this study did not provide clear evident that clinicians 
integrated T2DM screening to evaluate depression for diabetic patients; thus, not knowing if 
screening T2DM patients was integrated into the daily clinical practice could present as a 
possible potential weakness of this study.  
The study’s final limitation was that data collected from a small group may not yield an 




due to the limited number of interviewees. The original study included only eight participants 
recruited from the Saint Louis Missouri, Charleston Horn Lake, Calhoun City, Pora, Hernado, 
and Pope Mississippi of the United States. Due to the small sample, the data may not be 
generalized to other populations in other regions, possibly limiting transferability. 
Recommendations for Research 
One of the first recommendations for further study would be for researchers to design a 
study with various experience treating T2DM patients for depression. This study was designed to 
recruit participants with a level of experience treating T2DM patients for five years or greater. 
Conducting the same research with clinicians who are new to treating T2DM patients or who 
have only been treating T2DM patients for less than five years, may yield different results as 
new clinician may have a different view point or may have gain additional knowledge that may 
not have been provided to the participants who met the criteria for this present study. 
A second recommendation for future research is to seek participants from different 
geographical areas throughout the United States. This present study recruited participants from 
Saint Louis, Missouri, Charleston, Horn Lake, Calhoun City, Pora, Hernado, and Pope, 
Mississippi. Conducting this study over different geographical areas across the United States 
may results in different results as different states may have different guidelines and attitudes as it 
relates to screening forT2DM depression. 
Implications 
Based on the findings from this study, there are several implications for social change. A 
potential implication for social change could be the benefit to individuals living with T2DM 




depression. An individual living with T2DM would be diagnosed with depression, and treatment 
would begin earlier than later in the disease progression. Another implication clinician focusing 
on T2DM depression would be an enormous potential impact for positive social change for the 
individual and the medical community level. If clinicians emphasized screening individuals with 
T2DM for depression, the result could lead to early depression treatment. An additional 
implementation for social change could be the implementation of T2DM depression screening 
instruction for future clinicians seeking to serve this population.  
Conclusion 
This research study revealed that every participant believed it is beneficial to create a 
standard practice of screening T2DM parents for depression. Results showed that four of the 
participants screen their T2DM patients for depression and provide treatment when necessary. 
Results further revealed that peers approved of depression screening and saw this as an important 
additional to treatment planning for T2DM patients. This study extended the body of knowledge 
concerning clinicians’ phenomenon experience and lends insight into the process of depression 
screening perspective on the role of clinicians. The potential implication for social change on the 
individual and medical community level is that clinicians will more rapidly provide information 
to patients around T2DM depression and develop a process to provide treatment plans that 
address depression during the treatment of patient’s living with diabetes in an effort to provide 
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Appendix A: Interview Questions 
1. Do you talk to your Type 2 Diabetic patients about depression? 
a) If yes, please describe your process for talking with your patients. 
b) If no, please describe why you did not discuss depression with your patients. 
2. Do you screen T2DM patients for depression? 
a) If yes, please describe your process for screening T2DM patients for depression. 
b) If no, please describe why you do not screen T2DM patients for depression. 
3. What do you think the advantage and disadvantage of screening T2DM patients for 
depression? 
4. Do you think your peers would approve of screening T2DM patients for depression? 






Appendix B: Confidentiality Agreement 
 
Name of Signer:    
 
During the course of my activity in collecting data for this research: Vickie Bland will have 
access to information, which is confidential and should not be disclosed. I acknowledge that 
the information must remain confidential, and that improper disclosure of confidential 
information can be damaging to the participant.  
 
By signing this Confidentiality Agreement, I acknowledge and agree that: 
1. I will not disclose or discuss any confidential information with others, including friends or 
family. 
2. I will not in any way divulge, copy, release, sell, loan, alter or destroy any confidential 
information except as properly authorized. 
3. I will not discuss confidential information where others can overhear the conversation. I 
understand that it is not acceptable to discuss confidential information even if the 
participant’s name is not used. 
4. I will not make any unauthorized transmissions, inquiries, modification or purging of 
confidential information. 
5. I agree that my obligations under this agreement will continue after termination of the job that 
I will perform. 
6. I understand that violation of this agreement will have legal implications. 
7. I will only access or use systems or devices I am officially authorized to access, and I will not 
demonstrate the operation or function of systems or devices to unauthorized individuals. 
 
Signing this document, I acknowledge that I have read the agreement and I agree to comply with 
all the terms and conditions stated above. 
 
 
Signature:      Date: 
 








• Practice in Family Medical, Internal Medicine or Endocrinologist  
• Treat T2DM patients  
• English speaking 
• Medical License in the United States 
• Five Years of Experience in the field 
Exclusion Criteria: 





Appendix D: Demographic Information 
1. Demographics 









d. Education  
i. Bachelor Degree,  
ii. Doctor of Medicine (MD) 
iii. Doctor of Osteopathic Medicine (DO) 
e. Type of Doctor 
i. Medical practitioner 
ii. General practitioner 
iii. Internists  
iv. Endocrinologist 
v. Family Physicians 




i. Private Clinic 
ii. Hospital Medical center  
g. Length of time treating T2DM patients  
i. 5 years 
ii. 6-10 years 
iii. 11-15 years 
iv. 16-20 years 
v. 20 or more years 










Appendix E: Recruitment Letter to Participants 
Dear Sir or Madam: 
My name is Vickie Bland, and I am a doctoral student at Walden University. I am 
currently seeking participants for my doctoral dissertation study and am writing to see if you 
would like to participate in my study. . I am studying physicians’ or nurse practitioners’ 
perspectives on depression screening within diabetic patients and am currently seeking 
physicians or nurse practitioners to participate in this study.  
Participation in this research is voluntary and involves participating in one 60-minute 
interview. I plan to interview a select number of medical professionals’ face to face or a 
telephone call in this study.  
All of your responses to the interview questions will be kept anonymous. . The interview 
will take 60 minutes, and the interview will be scheduled convenient to you and your workplace. 
If you would like to participate, please respond to this email indicating you are interested in 
participating.  A follow-up email will then be sent to confirm participation and to schedule an 
interview time.  
 
Sincerely yours, 
Vickie Bland 
 
 
 
